comparemela.com

Equities researchers at StockNews.com started coverage on shares of OncoCyte (NYSE:OCX – Get Rating) in a research report issued on Tuesday. The firm set a “sell” rating on the stock. OncoCyte Price Performance Shares of OCX opened at $0.22 on Tuesday. OncoCyte has a 1 year low of $0.20 and a 1 year high of […]

Related Keywords

,Oncocyte Corp ,Get Rating ,Oncocyte Daily ,Oncocyte ,Nyse Ocx ,Socx ,Health Technology ,Initiated Coverage ,Stocknews Com ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.